Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval

This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with recommendations for drug approval.